1. Home
  2. PTGX vs VEON Comparison

PTGX vs VEON Comparison

Compare PTGX & VEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTGX
  • VEON
  • Stock Information
  • Founded
  • PTGX 2006
  • VEON 1992
  • Country
  • PTGX United States
  • VEON United Arab Emirates
  • Employees
  • PTGX N/A
  • VEON N/A
  • Industry
  • PTGX Biotechnology: Pharmaceutical Preparations
  • VEON Telecommunications Equipment
  • Sector
  • PTGX Health Care
  • VEON Telecommunications
  • Exchange
  • PTGX Nasdaq
  • VEON Nasdaq
  • Market Cap
  • PTGX 5.0B
  • VEON 3.6B
  • IPO Year
  • PTGX 2016
  • VEON 1996
  • Fundamental
  • Price
  • PTGX $85.09
  • VEON $48.66
  • Analyst Decision
  • PTGX Strong Buy
  • VEON Strong Buy
  • Analyst Count
  • PTGX 9
  • VEON 4
  • Target Price
  • PTGX $86.44
  • VEON $73.25
  • AVG Volume (30 Days)
  • PTGX 991.5K
  • VEON 121.0K
  • Earning Date
  • PTGX 11-06-2025
  • VEON 11-10-2025
  • Dividend Yield
  • PTGX N/A
  • VEON N/A
  • EPS Growth
  • PTGX N/A
  • VEON N/A
  • EPS
  • PTGX 0.72
  • VEON 8.21
  • Revenue
  • PTGX $209,217,000.00
  • VEON $4,226,000,000.00
  • Revenue This Year
  • PTGX N/A
  • VEON $10.11
  • Revenue Next Year
  • PTGX $140.23
  • VEON $7.76
  • P/E Ratio
  • PTGX $118.80
  • VEON $6.09
  • Revenue Growth
  • PTGX N/A
  • VEON 6.85
  • 52 Week Low
  • PTGX $33.31
  • VEON $30.20
  • 52 Week High
  • PTGX $93.25
  • VEON $64.00
  • Technical
  • Relative Strength Index (RSI)
  • PTGX 69.75
  • VEON 48.71
  • Support Level
  • PTGX $76.70
  • VEON $42.60
  • Resistance Level
  • PTGX $80.43
  • VEON $51.50
  • Average True Range (ATR)
  • PTGX 2.93
  • VEON 2.07
  • MACD
  • PTGX 0.29
  • VEON 0.07
  • Stochastic Oscillator
  • PTGX 94.70
  • VEON 67.76

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

About VEON VEON Ltd. ADS

VEON Ltd is a United Arab Emirates-based digital operator providing connectivity and Internet services to corporations and individuals. The company offers mobile and fixed-line telecommunications services through a range of traditional and broadband mobile technologies. The company's reportable segments consist of the following five segments: Pakistan, Ukraine, Kazakhstan, Bangladesh, and Uzbekistan. It provides its services under the Beeline, Kyivstar, Banglalink, and Jazz brands. It generates the majority of its revenue from Pakistan.

Share on Social Networks: